| Actinobacteria: A relevant minority for the maintenance of gut homeostasis |
24 |
| Novel biomarkers in hepatocellular carcinoma |
21 |
| Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) |
21 |
| Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases |
20 |
| Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals |
18 |
| Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis |
18 |
| Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) |
17 |
| Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] |
16 |
| Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals |
14 |
| Colo-rectal endoscopic full-thickness resection (EFTR) with the over-the-scope device (FTR (R)): A multicenter Italian experience |
14 |
| Familial intrahepatic cholestasis: New and wide perspectives |
14 |
| Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) |
14 |
| Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals |
14 |
| Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis |
13 |
| Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) |
13 |
| Both glypican-3/Wnt/beta-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma |
12 |
| When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review |
11 |
| Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) |
11 |
| Nutritional composition of gluten-free food versus regular food sold in the Italian market |
11 |
| Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) |
11 |
| Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects |
10 |
| Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals |
10 |
| Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study |
10 |
| Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation |
10 |
| Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence |
10 |
| Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma |
10 |
| The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases |
9 |
| The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis |
9 |
| Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) |
9 |
| The epidemiology of Budd-Chiari syndrome in France |
9 |
| EUS-guided core biopsies of pancreatic solid masses using a new fork-tip needle: A multicenter prospective study |
9 |
| Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature |
9 |
| Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis |
9 |
| Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis |
9 |
| Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota |
9 |
| Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019 |
9 |
| FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury |
9 |
| Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5 |
9 |
| Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma |
8 |
| Novel ultrasound-based methods to assess liver disease: The game has just begun |
8 |
| Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment-A multicenter retrospective study |
8 |
| Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity |
8 |
| Hepatotoxicity of immune check point inhibitors: Approach and management |
8 |
| Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis |
8 |
| Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study |
8 |
| Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study |
8 |
| MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/beta-catenin signaling pathway |
8 |
| Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients |
8 |
| Presence of hepatitis B virus markers in umbilical cord blood: Exposure to or infection with the virus? |
7 |
| Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis |
7 |
